Market Place
Sourcing Support
All News #Library
Quality
FDA Warns Three Firms For GMP Violations, Cites Incyte
30 Apr 2026 //
RAPS
Incyte Lung Cancer Expansion Hit by Issues at Novo Catalent Site
09 Mar 2026 //
BIOSPACE
Incyte hit by CRL on extended-release JAK tablets
25 Mar 2023 //
ENDPTS
Complaint reveals quality woes with Incyte`s eczema cream—again
20 Apr 2022 //
FIERCEPHARMA
EMA Assessment of Incyte Biosciences` Iclusig (ponatinib) & Procedural steps
10 Oct 2018 //
EMA
FDA Approves OLUMIANT® for Moderately-to-Severe Active Rheumatoid Arthritis
01 Jun 2018 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.